Skip to search formSkip to main contentSkip to account menu

Malignant neoplasm of ovary

Known as: ovarian ca, -- Ovarian Cancer, Ovarian cancer 
Cancer that forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Most ovarian cancers… 
National Institutes of Health

Related topics

Related topics

37 relations
ADAM11 geneBIRC6 geneBIRC6 protein, humanBIRC6 wt Allele

Narrower (3)

Malignant Brenner TumorOvarian Carcinomaovarian adenocarcinoma

Broader (2)

Neoplasm, uncertain whether benign or malignantovarian neoplasm

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Ovarian cancer statistics, 2018
In 2018, there will be approximately 22,240 new cases of ovarian cancer diagnosed and 14,070 ovarian cancer deaths in the United… 
Highly Cited
2011
Highly Cited
2011
Incorporation of bevacizumab in the primary treatment of ovarian cancer.
BACKGROUND Vascular endothelial growth factor is a key promoter of angiogenesis and disease progression in epithelial ovarian… 
Highly Cited
2010
Highly Cited
2010
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
Highly Cited
2008
Highly Cited
2008
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
Review
2006
Review
2006
Ecological and toxicological effects of inorganic nitrogen pollution in aquatic ecosystems: A global assessment.
Highly Cited
2005
Highly Cited
2005
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.
In a recent report, [Zhang et al. (2003) N. Engl. J. Med. 348, 203-213], the presence of CD3+ tumor-infiltrating lymphocytes… 
Highly Cited
2004
Highly Cited
2004
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
Purpose: The purpose of this study was to determine the accuracy, precision, and linearity of the CellSearch system and evaluate… 
Highly Cited
2003
Highly Cited
2003
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is… 
Highly Cited
2003
Highly Cited
2003
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
Risks of breast and ovarian cancer were determined for Ashkenazi Jewish women with inherited mutations in the tumor suppressor… 
Highly Cited
1989
Highly Cited
1989
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.
Carcinoma of the breast and ovary account for one-third of all cancers occurring in women and together are responsible for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)